All Type of News
Pharmaceutical firms put focus on more CI ads on trade papers
Under slight prospects for an economic turnaround amid deepened business slump in a local pharmaceutical sector and less frequency of pharmacy visits by patients for purchase of nutrients, etc., local drug makers seem...
HIRA to disclose screening details of drug-related applications next month
The Health Insurance Review Agency said recently that from this March, all procedures involving approval or rejection of drug-related applications by the Diagnosis Screening Evaluation Committee will be opened to the ...
Dowzon Pharm to boost exports in Middle East
Kim Jae-soo, CEO of a bioventure enterprise Dowzon Pharm and president of Daesung Pharm said on February 20 that it agreed with a certain firm of U.A.E to sign an agreement for the exportation of Momezon, a nutritiona...
Lilly Korea to open Cialis Call Center for pharmacists and physicians.
Lilly Korea announced on Feb. 19 that "Cialis Call Center" (Phone: 02-3459-2676), a drug information website for Cialis and other medication for doctors, pharmacists and other medical workers, set up for the purpose o...
Most KGMP plants found poor in quality control and production.
The KFDA announced on Feb. 19 that 187 companies (48.6%) out of the total 385 pharmaceutical plants found poor in their quality controls and productions according to the report of the 2003 regular pharmaceutical inspe...
Kang Shin-ho, new head of Federation of Korean Industries
The Federation of the Korean Industries, a leading business lobby, said on February 18 it appointed Kang Shin-ho, chairman of Dong-A Pharmaceutical Co., as its new head at the 48th general meeting. He will be the new ...
Government urged to promote substitute drug dispensing
In the National Assembly's interpellation session on February 19, Rep. Kim Sung-soon of the former ruling Millennium Democratic Party said that substitute drug dispensing system for bioequivalence-tested drugs should ...
Choong-wae Pharm strengthens its domestic presence by acquiring exclusive marketing right to GABITRI
Choong-wae Pharm said recently that for the local introduction of Gabitril tablet (tiagabine HCl), an antiepilepsy drug, it entered into another exclusive distribution agreement with the U.S.-based Anesta Corporation,...
KHIDI to subsidy bio Industry in Chooncheon area.
The KHIDI (President: Mr. Lee Kyeong-ho) has recently made an agreement with Chooncheon Bio Industry Development Institute(CBIDI) (Head: Mr. Yoo Jong-soo) for the technology trade and assessment, and decided to explor...
Health Industry Venture Group to have a strategic conference.
The Health Industry Venture Association (HIVA), a judicial corporation, (President: Mr. Park In-chool) plans to have a strategic conference titled "A forum invited civilian and government officials for the strategic f...
